Interaction of MHC class II molecules with the invariant chain: Role of the invariant chain (81-90) region

EMBO Journal

Volumn 16, Issue 19, 1997, Pages 5807-5818

  Stumptner, Pamela ^a   Benaroch, Philippe ^a  

^a INSTITUT COCHIN   (France)

Author keywords

CLIP; Ii chain association; In vitro translation; Inhibition of peptide binding; MHC class II

Indexed keywords

HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUTANT PROTEIN; PROTEIN SUBUNIT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; COS CELLS; DETERGENTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR1 ANTIGEN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; SODIUM DODECYL SULFATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030832073     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7590555     Document Type: Article

References (59)

1. Adams,S. and Humphreys,R.E. (1995) Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules. Eur. J. Immunol., 25, 1693-1702.
2. Adams,T.E., Bodmer,J.G. and Bodmer,W.F. (1983) Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. Immunology, 50, 613-624.
3. Amigorena,S., Webster,P., Drake,J., Newcomb,J., Cresswell,P. and Mellman,I. (1995) Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med., 181, 1729-1741.
4. Anderson,M.S. and Miller,J. (1992) Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl Acad. Sci. USA, 89, 2282-2286.
5. Arneson,L.S. and Miller,J. (1995) Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J. Cell Biol., 129, 1217-1228.
6. Avva,R.R. and Cresswell,P. (1994) In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity, 1, 763-774.
7. Bakke,O. and Dobberstein,B. (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell, 63, 707-716.
8. Bell,J.I., Estess,P., John,T.S., Saiki,R., Watling,D.L., Erlich,H.A. and McDevitt,H.O. (1985) DNA sequence and characterization of human class II major histocompatibility complex β chains from the DR1 haplotype. Proc. Natl Acad. Sci. USA, 82, 3405-3409.
9. Bertolino,P. et al. (1995) Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J. Immunol., 154, 5620-5629.
10. Bijlmakers,M.J., Benaroch,P. and Ploegh,H.L. (1994a) Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J., 13, 2699-2707.
11. Bijlmakers,M.J., Benaroch,P. and Ploegh,H.L. (1994b) Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med., 180, 623-629.
12. Busch,R., Cloutier,I., Sekaly,R.P. and Hammerling,G.J. (1996) Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J., 15, 418-428.
13. Chicz,R.M., Urban,R.G., Lane,W.S., Gorga,J.C., Stern,L.J., Vignali, D.A.A. and Strominger,J.L. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature, 358, 764-768.
14. Claesson,X., Larhammer,D., Rask,L. and Peterson,P.A. (1983) cDNA clone for the human γ chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl Acad. Sci. USA, 80, 7395-7399.
15. Cresswell,P. (1996) Invariant chain structure and MHC class II function. Cell, 84, 505-507.
16. Freisewinkel,I., Scenck,K. and Koch,N. (1993) The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl Acad Sci. USA, 90, 9703-9706.
17. Gedde-Dahl,M., Freisewinkel,I., Staschewski,M., Schenck,K., Koch,N. and Bakke,O. (1997) Exon 6 is essential for invariant chain trimerization and induction of large endosomal structure. J. Biol. Chem., 212, 8281-8287.
18. Germain,R.N. and Hendrix,L.R. (1991) MHC class II structure. occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature, 353, 134-139.
19. Germain,R.N., Castellino,F., Han,R., Reis e Sousa,C., Romagnoli,P., Sadegh-Nasseri,S. and Zhong,G.-M. (1996) Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules. Immunol. Rev., 151, 5-30.
20. Ghosh,P. Amaya,M., Mellins,E. and Wiley,D.C. (1995) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature, 378, 457-462.
21. Hammer,J., Takacs,B. and Sinigaglia,F. (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med., 176, 1007-1013.
22. Hammer,J., Valsasnini,P., Tolba,K., Bolin,D., Higelin,J., Takacs,B. and Sinigaglia,F. (1993) Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell, 74, 197-203.
23. Hammer,J., Belunis,C., Bolin,D., Papadopoulos,J., Walsky,R., Higelin,J., Danho,W., Sinigaglia,F. and Nagy,Z.A. (1994) High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl Acad. Sci. USA, 91, 4456-4460.
24. Hedley,M.L., Urban,R.G. and Strominger,J.L. (1994) Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system. Proc, Natl Acad. Sci. USA, 91, 10479-10483.
25. Jardetzky,T.S., Gorga,J.C., Busch,R., Rothbard,J., Strominger,J.L. and Wiley,D.C. (1990) Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J., 9, 1797-1803.
26. Kozak,M. (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol., 115, 887-903.
27. Kropshofer,H., Max,H. and Kalbacher,H. (1993) Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer. Proc. Natl Acad. Sci. USA, 90, 403-407.
28. Kropshofer,H., Vogt,A.B. and Hammerling,G.J. (1995a) Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc. Natl Acad. Sci. USA, 92, 8313-8317.
29. Kropshofer,H., Vogt,A.B., Stern,L.J. and Hämmerling,G.J. (1995b) Self-release of CLIP in peptide loading of HLA-DR molecules. Science, 270, 1357-1359.
30. Kropshofer,H., Hämmerling,G.J. and Vogt,A.B. (1997) How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today, 18, 77-82.
31. Lamb,C. and Cresswell,P. (1992) Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol., 148, 3478-3482.
32. Larhammer,D. et al. (1982) Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins. Cell, 30, 153-161.
33. Layet,C. and Germain,R.N. (1991) Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/ cis-Golgi compartment. Proc. Natl Acad. Sci. USA, 88, 2346-2350.
34. Lotteau,V., Teyton,L., Peleraux,A., Nilsson,T., Karlsson,L., Schmid,S.L., Quaranta,V. and Peterson,P.A. (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature, 348, 600-605.
35. Morkowski,S., Goldrath,A.W., Eastman,S., Ramachandra,L., Freed,D.C., Whiteley,P. and Rudensky,A. (1995) T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Med., 182, 1403-1413.
36. Newcomb,J., Carboy-Newcomb,C. and Cresswell,P. (1996) Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II dimers. J. Biol. Chem., 271, 24249-24256.
37. Odorizzi,C.G., Trowbridge,I.S., Xue,L., Hopkins,C.R., Davis,C.D. and Collawn,J.F. (1994) Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol., 126, 317-330.
38. O'Sullivan,D. et al. (1991a) On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol., 147, 2663-2669.
39. O'Sullivan,D., Sidney,J., Del,G.M., Colon,S.M. and Sette,A. (1991b) Truncation analysis of several DR binding epitopes. J. Immunol., 146, 1240-1246.
40. Park,S.J., Sadegh-Nasseri,S. and Wiley,D.C. (1995) Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl Acad. Sci. USA, 92, 11289-11293.
41. Pieters,J., Bakke,O. and Dobberstein,B. (1993) The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci., 106, 831-846.
42. Riberdy,J.M., Newcomb,J.R., Surman,M.J., Barbosa,J.A. and Cresswell,P. (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature, 360, 474-176.
43. Roche,P.A. (1995) HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity, 3, 259-262.
44. Roche,P.A. and Cresswell,P. (1990) High-affinity binding of an influenza haemagglutinin-derived peptide to purified HLA-DR. J. Immunol., 144, 1849-1856.
45. Roche,P.A., Marks,M.S. and Cresswell,P. (1991) Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature. 354, 392-394.
46. Romagnoli,P. and Germain,R.N. (1994) The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med., 180, 1107-1113.
47. Rothbard,J.B., Lechler,R.I., Howland,K., Bal,V., Eckels,D.D., Sekaly,R., Long,E.O., Taylor,W.R. and Lamb,J.R. (1988) Structural model of HLA-DR1 restricted T cell antigen recognition. Cell, 52, 515-523.
48. Rudensky,A.Y., Preston-Hurlburt,P., Hong,S.C., Barlow,A. and Janeway,C.A. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature, 353, 622-627.
49. Sette,A. et al. (1992) Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science, 258, 1801-1804.
50. Sette,A., Southwood,S., Miller,J. and Appella,E. (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med., 181, 677-683.
51. Shaw,S., Ziegler,A. and De Mars,R. (1985) Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Hum. Immunol., 12, 191-211.
52. Stern,L.J., Brown,J.H., Jardetsky,J.C., Gorga,R.G., Urban,J.L. and Wiley,D.C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature, 368, 215-221.
53. Teyton,L., O'Sullivan,D., Dickson,P.W., Lotteau,V., Sette,A., Fink,P. and Peterson,P.A. (1990) Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature, 348, 39-44.
54. Unanue,E.R. (1992) Cellular studies on antigen presentation by class II MHC molecules. Cun: Opin. Immunol., 4, 63-69.
55. Urban,R.G., Chicz,R.M. and Strominger,J.L. (1994) Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med., 180, 751-755.
56. Vogt,A.B., Stern,L.J., Amshoff,C., Dobberstein,B., Hammerling,G.J. and Kropshofer,H. (1995) Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol., 155, 4757-4765.
57. Wolf,P.R. and Ploegh,H.L. (1995) How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol., 11, 267-306.
58. Wraight,C.J., Van Endert,P., Möller,P., Lipp,J., Ling,N.R., MacLennan,I.C.M., Koch,N. and Moldenhauer,G. (1990) Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol Chem., 265, 5787-5792.
59. Zhong,G., Castellino,F., Romagnoli,P. and Germain,R.N. (1996) Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med., 184, 2061-2066.